Logo

Similar Products

Description

Hydrea Hydroxyurea 500mg capsules represent a vital pharmaceutical solution in cancer treatment and blood disorder management. This antineoplastic medication contains hydroxyurea a...
Hydrea Hydroxyurea 500mg capsules represent a vital pharmaceutical solution in cancer treatment and blood disorder management. This antineoplastic medication contains hydroxyurea as its active ingredient, specifically formulated to inhibit DNA synthesis in rapidly dividing abnormal cells. The standardized 500mg capsule formulation ensures precise dosing and consistent therapeutic outcomes for patients undergoing treatment. Manufactured under stringent quality control protocols, this medication maintains pharmaceutical excellence that healthcare providers and distributors can trust for reliable patient care across various medical settings.

This medication serves specialized medical fields including oncology, hematology, and immunology where effective treatments for specific conditions are essential. Hospitals and cancer treatment centers utilize Hydrea for managing refractory ovarian cancer cases that have not responded to conventional therapies. Hematologists employ this medication for polycythemia vera to control excessive red blood cell production, while immunologists use it for hypereosinophilic syndrome to manage elevated eosinophil levels. The product meets the demanding requirements of medical institutions that prioritize evidence-based treatments and reliable pharmaceutical solutions for complex patient conditions across diverse healthcare environments.

For importers and distributors, Hydrea Hydroxyurea 500mg offers substantial value through its consistent quality, reliability, and established market demand within the pharmaceutical sector. The medication provides a trusted therapeutic option that healthcare facilities regularly require, ensuring steady demand and inventory movement. Its standardized formulation and proven efficacy make it a valuable addition to pharmaceutical portfolios serving medical institutions. The product's reliability stems from strict manufacturing standards and quality assurance processes that guarantee consistent performance and patient safety, making it a preferred choice for serious buyers seeking pharmaceutical products they can distribute with confidence.

Key Features:
- Contains 500mg hydroxyurea as the active pharmaceutical ingredient
- Belongs to the antineoplastic class of medications
- Standardized capsule formulation for precise dosing accuracy
- Manufactured under strict quality control protocols
- Specifically indicated for multiple complex medical conditions

Benefits:
- Provides targeted therapeutic action for specific conditions
- Ensures consistent dosing and treatment outcomes
- Meets stringent pharmaceutical quality standards
- Supports reliable patient care across medical settings
- Maintains steady demand within healthcare distribution networks

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Hydrea Hydroxyurea 500mg capsules serve critical roles in oncology and hematology departments for managing complex conditions. This medication effectively inhibits DNA synthesis in abnormal cells, providing targeted therapeutic action for patients requiring specialized pharmaceutical interventions. Healthcare professionals depend on its consistent performance for treating refractory cancers and blood disorders where precision and reliability are paramount.

Medical institutions including hospitals, specialized clinics, and cancer treatment centers utilize this medication for patients with specific conditions. Distributors and wholesalers can confidently supply this product to facilities managing refractory ovarian cancer, polycythemia vera, and hypereosinophilic syndrome. The standardized 500mg capsule formulation ensures consistent dosing across various treatment protocols and healthcare settings.
- Treatment of refractory ovarian cancer in hospital oncology departments
- Management of polycythemia vera in hematology clinics and specialized care centers
- Therapeutic intervention for hypereosinophilic syndrome in clinical settings
- Supply to pharmaceutical distributors serving cancer treatment facilities
- Inventory for wholesalers providing medications to hospitals and specialized healthcare providers

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
Verified
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Hydrea Hydroxyurea 500mg Capsules for Cancer and Blood Disorders

Hydrea Hydroxyurea 500mg capsules are trusted antineoplastic medication for treating refractory ovarian cancer, polycythemia vera, and hypereosinophilic syndrome, offering reliable quality for healthcare distributors.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products